Evidence map›Paper›PMID 40936943›Full record

ArticleAPL bioengineering2025

Analysis of immune cell infiltration landscape and identification of diagnostic biomarkers in ankylosing spondylitis.

Meng Chen, Shanbang Zhu, Yue Gu, Xinzhe Feng

Abstract read
In one paragraph

Article in APL bioengineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Meng ChenDepartment of Nephrology, Henan Clinical Medical Research Center for Nephropathy, Henan Provincial Key Laboratory of Kidney Disease and Immunology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, China.ORCID https://orcid.org/0009-0007-3004-5882
Shanbang ZhuDepartment of Orthopedics, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Yue Gu
Xinzhe FengDepartment of Joint Bone Disease Surgery, Changhai Hospital, Naval Medical University, Shanghai, China.ORCID https://orcid.org/0000-0001-7072-095X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ankylosing spondylitis (AS), characterized by inflammation of sacroiliac joints and spinal attachments, has an unclear pathogenesis. This study aims to screen and authenticate immune cell-associated biomarkers in AS. Two Gene Expression Omnibus datasets (GSE25101 and GSE41038) were combined as the discovery dataset, with candidate biomarkers screened via differential expression analysis, immune cell infiltration analysis, and weighted gene co-expression network analysis (WGCNA). Immune cell-related biomarkers were further identified and validated by receiver operating characteristic (ROC) analysis using the confirmatory dataset GSE73754, and potential diagnostic biomarkers were finally confirmed by reverse transcription quantitative polymerase chain reaction (RT-qPCR), immunofluorescence staining, and single-cell RNA sequencing (scRNA-seq) analysis (GSE194315). Thirty-two differentially expressed genes between the AS and control samples were identified. The ratio of M2 macrophages was significantly different between the AS and control samples. Seven candidate biomarkers associated with immune cells in AS were identified by WGCNA and Venn diagram. Then, three genes (SBK1, HNRPR, and CX3CR1) were authenticated as immune cell-associated biomarkers in AS by ROC curves, indicating a possible diagnostic value in clinical settings. The results of RT-qPCR, immunofluorescence staining, and scRNA-seq analysis all confirmed that CX3CR1 was down-regulated in AS, which was in line with bioinformatics study findings. Dysregulation of the CX3CR1 and M2-type macrophage ratio are key factors in AS, which lay the groundwork for exploring illness pathophysiology and yielding fresh perspectives on AS diagnosis and therapy.

Identifiers

PMID40936943
PMCPMC12422756

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.